Home » Jonas Ohlsson

Jonas Ohlsson

May 01, 2008
Premium
Cellectricon, a Swedish screening technology developer, has appointed Jonas Ohlsson as its president and CEO.
 
Ohlsson was previously the CEO of Mentice, a developer of patient-safety products, and has held executive positions at Perkin Elmer, Applied Biosystems,and AstraZeneca.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Like Sears, But With Cells

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Infertile Mouse No More

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

PGD Growth Spurt

China is embracing preimplantation genetic diagnosis, Nature News reports. 

This Week in PLOS

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.

Sep
12
Featured Webinar

GenomeWeb/ABRF 2017 Webinar Series: Next-Generation CRISPR: New Tools for Efficient Genome Engineering

Sponsored by
PerkinElmer

This webinar will cover recent advances in the use of CRISPR for generating animal models and cell lines. 

What's Popular?

In Gene Silencing/Gene Editing

  1. Monsanto Licenses ToolGen CRISPR Technology

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.